Clinical Trials Directory

Trials / Completed

CompletedNCT05552482

Identifying Risk Factors (RF) for Early Haemodialysis Arteriovenous Fistula Failure (eAVFF)

Identification of Factors That Predict Early Haemodialysis Arteriovenous Fistula Failure

Status
Completed
Phase
Study type
Observational
Enrollment
105 (actual)
Sponsor
Centre Hospitalier Régional Metz-Thionville · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Arteriovenous fisutla (AVF) is the vascular access of choice for hemodialysis but has a high early failure (eAVFF) rate. eAVFF can be defined as thrombosis/stenosis and Doppler ultrasound (DUS)-based failure-to-mature parameters such as postoperative blood flow (PostQa) \< 500 ml/min, AVF-vein diameter (PostVD) \< 5 mm, and AVF-vein depth (PostVDepth) ≥ 6 mm. We explored whether common risk factors for eAVFF could predict these eAVFF parameters and venous distensibility: the latter is largely overlooked as a potential eAVFF parameter.

Conditions

Interventions

TypeNameDescription
OTHERIdentification of predictive factorsEvaluation of the following variables : age, sex, body mass index, Diabetes mellitus, vascular disease, hematologic disease, venous thromboembolic disease, antiplatelet or anticoagulant treatments, haemodialysis Catheter Insertion, number of comorbid conditions, Venous diameter, Arterial diameter, AVF type, AVF limb, Anasthesia group

Timeline

Start date
2021-01-05
Primary completion
2021-10-05
Completion
2022-12-21
First posted
2022-09-23
Last updated
2023-03-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05552482. Inclusion in this directory is not an endorsement.